Cargando…

A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy

Fluorescence image-guided surgery combined with intraoperative therapeutic modalities has great potential for intraoperative detection of oncologic targets and eradication of unresectable cancer residues. Therefore, we have developed an activatable theranostic nanoplatform that can be used concurren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaoning, Schumann, Canan, Albarqi, Hassan A., Lee, Christopher J., Alani, Adam W. G., Bracha, Shay, Milovancev, Milan, Taratula, Olena, Taratula, Oleh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771092/ https://www.ncbi.nlm.nih.gov/pubmed/29344305 http://dx.doi.org/10.7150/thno.21209

Ejemplares similares

Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy
por: Taratula, Olena, et al.
Publicado: (2015)

Novel Nanoparticle-Based Treatment and Imaging Modalities
por: Taratula, Oleh, et al.
Publicado: (2023)

Stimuli-activatable nanomedicine meets cancer theranostics
por: Li, Haonan, et al.
Publicado: (2023)

Systemically Delivered Magnetic Hyperthermia for Prostate Cancer Treatment
por: Albarqi, Hassan A., et al.
Publicado: (2020)

Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA
por: Schumann, Canan, et al.
Publicado: (2018)

A novel multimodal nanoplatform for targeting tumor necrosis
por: Han, Xiangjun, et al.
Publicado: (2021)

Targeting Estrogen Receptor-Positive Breast Microtumors with Endoxifen-Conjugated, Hypoxia-Sensitive Polymersomes
por: Mamnoon, Babak, et al.
Publicado: (2021)

A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous Disease()
por: Brady, Jacqueline V., et al.
Publicado: (2018)

From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics
por: Korzun, Tetiana, et al.
Publicado: (2023)

Dual-channel NIR activatable theranostic prodrug for in vivo spatiotemporal tracking thiol-triggered chemotherapy
por: Ye, Mingzhou, et al.
Publicado: (2016)

Activatable NIR-II organic fluorescent probes for bioimaging
por: Zhang, Xiaoning, et al.
Publicado: (2022)

NIR light-activatable dissolving microneedle system for melanoma ablation enabled by a combination of ROS-responsive chemotherapy and phototherapy
por: Liu, Fan, et al.
Publicado: (2023)

Discovery and Validation of a Compound to Target Ewing’s Sarcoma
por: Esfandiari Nazzaro, Ellie, et al.
Publicado: (2021)

Activatable molecular agents for cancer theranostics
por: Zhang, Jianjian, et al.
Publicado: (2019)

NIR-driven Smart Theranostic Nanomedicine for On-demand Drug Release and Synergistic Antitumour Therapy
por: Zhao, Pengfei, et al.
Publicado: (2015)

A plasmon-enhanced theranostic nanoplatform for synergistic chemo-phototherapy of hypoxic tumors in the NIR-II window
por: Chen, Ming-Ming, et al.
Publicado: (2021)

Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention
por: Garbuzenko, Olga B., et al.
Publicado: (2014)

A pH reversibly activatable NIR photothermal/photodynamic-in-one agent integrated with renewable nanoimplants for image-guided precision phototherapy
por: Zhao, Xu, et al.
Publicado: (2020)

Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2019)

Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy
por: Garbuzenko, Olga B., et al.
Publicado: (2019)

Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer
por: Pavuluri, KowsalyaDevi, et al.
Publicado: (2022)

Dual-targeting nanozyme for tumor activatable photo-chemodynamic theranostics
por: Chen, Chaoyi, et al.
Publicado: (2022)

A Smart and Versatile Theranostic Nanomedicine Platform based on Nanoporphyrin
por: Li, Yuanpei, et al.
Publicado: (2014)

Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
por: Xu, Xiao, et al.
Publicado: (2023)

Theranostic nanomedicine: Potential therapeutic epitome
por: Nagaich, Upendra
Publicado: (2015)

Corrigendum: Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2020)

Editorial: Advanced Theranostic Nanomedicine in Oncology
por: Tapeinos, Christos, et al.
Publicado: (2020)

Industrialization’s eye view on theranostic nanomedicine
por: Sivasubramanian, Maharajan, et al.
Publicado: (2022)

Theranostic nanomedicine for cancer detection and treatment
por: Fan, Zhen, et al.
Publicado: (2014)

Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023)

Recent Progress of Gold-Based Nanostructures towards Future Emblem of Photo-Triggered Cancer Theranostics: A Special Focus on Combinatorial Phototherapies
por: Sekar, Rajkumar, et al.
Publicado: (2023)

Crystallographic observation of 'induced fit' in a cryptophane host–guest model system
por: Taratula, Olena, et al.
Publicado: (2010)

Rethinking Brain Cancer Therapy: Tumor Enzyme Activatable Theranostic Nanoparticles
por: Daldrup-Link, Heike E.
Publicado: (2017)

Nanotechnology-based combinatorial phototherapy for enhanced cancer treatment
por: Chen, Han, et al.
Publicado: (2022)

A Supramolecular Nanoassembly of Lenvatinib and a Green Light-Activatable NO Releaser for Combined Chemo-Phototherapy
por: Laneri, Francesca, et al.
Publicado: (2022)

Advances in nanotheranostics II: cancer theranostic nanomedicine
por: Dai, Zhifei
Publicado: (2016)

Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
por: Baeza, Alejandro, et al.
Publicado: (2020)

Insights into Theranostic Properties of Titanium Dioxide for Nanomedicine
por: Hasanzadeh Kafshgari, Morteza, et al.
Publicado: (2020)

Advanced Peptide Nanomedicines for Bladder Cancer Theranostics
por: Zeng, Sheng, et al.
Publicado: (2022)

Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro
por: Milovancev, Milan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_th7nh0fo4q6agdjtftton5sa1n